Lipogenesis is important in the development of nonalcoholic fatty liver disease (NAFLD) which was known regulated mainly by AMP-activated protein kinase (AMPK) and sterol regulatory element-binding protein (SREBP-1C). This evidence concerns the gene CNBP and metabolic dysfunction-associated steatotic liver disease.